Skip to main content

Advertisement

Log in

Effects of sacral neuromodulation on female sexual function

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

The aim of this prospective study was to determine if sacral neuromodulation has an effect on the patient’s subsequent sexual function. Sexually active patients that underwent an Interstim® Sacroneuromodulator implantation (Medtronic, Minneapolis, MN) for control of bladder symptoms were enrolled. A Female Sexual Function Index (FSFI) was completed before surgery and at a mean of 5.7 months postoperatively. Eleven subjects proceeded to permanent implantation, seven of these were sexually active before and after placement. Three subjects (43%) felt the device impacted on their sexual function in a positive way (1) by decreasing urgency and (2) by increasing desire. Overall sexual frequency increased significantly after the surgery (p=0.047). There were also significant increases in the FSFI total (p=0.002), and domain scores for desire (p=0.004), lubrication (p=0.005), orgasm (p=0.043), satisfaction (p=0.007), and pain (p=0.015). There was no correlation between patient report of urinary symptom improvement and FSFI scores. In conclusion, sacral neuromodulation may improve sexual frequency and sexual function scores in subjects with urgency frequency and urge incontinence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Leng WW, Chancellor MB (2005) How sacral nerve stimulation neuromodulation works. Urol Clin North Am 32(1):11–18

    Article  PubMed  Google Scholar 

  2. Bernstein AJ, Peters KM (2005) Expanding indications for neuromodulation. Urol Clin North Am 32(1):59–63

    Article  PubMed  Google Scholar 

  3. Jarrett ME, Nicholls RJ, Kamm MA (2005) Effect of sacral neuromodulation for faecal incontinence on sexual activity. Colorectal Dis 7(5):523–525

    Article  PubMed  CAS  Google Scholar 

  4. Meston CM (2003) Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 29(1):39–46

    PubMed  Google Scholar 

  5. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208

    Article  PubMed  CAS  Google Scholar 

  6. McKenna KE (2002) The neurophysiology of female sexual function. World J Urol 20(2):93–100

    Article  PubMed  Google Scholar 

  7. O’Connell HE, Sanjeevan KV, Hutson JM (2005) Anatomy of the clitoris. J Urol 174(4 Pt 1):1189–1195

    Article  PubMed  Google Scholar 

  8. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N (2002) Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 11(4):367–377

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel N. Pauls.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pauls, R.N., Marinkovic, S.P., Silva, W.A. et al. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J 18, 391–395 (2007). https://doi.org/10.1007/s00192-006-0168-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-006-0168-9

Keywords

Navigation